Literature DB >> 18715840

Pulmonary irritation after inhalation exposure to benzalkonium chloride in rats.

Radosław Swiercz1, Tadeusz Hałatek, Wojciech Wasowicz, Barbara Kur, Zofia Grzelińska, Wanda Majcherek.   

Abstract

BACKGROUND: Benzalkonium chloride (BAC) is a quaternary ammonium compound (QAC) with a C8 to C18 chain length of alkyl groups. Since BAC exerts toxic effects on microorganisms, it has been used as an effective germicide and preservative, mostly in cosmetic industry and medicine. However, the toxic potential of BAC may be hazardous to humans, due to the common use of preparations containing BAC as a preservative.
MATERIAL AND METHODS: To assess the possible toxic effects of BAC, two-stage experiments were performed on female Wistar rats. At first, LC50 after a single exposure to BAC aerosol was determined. Then, the animals were exposed to BAC aerosol at 30 mg/m3 for 6 h, and for 3 days (6 h/day). The controls were unexposed rats. Directly after BAC exposure and 18 h afterwards, BALF concentrations were measured of total protein, Clara cell protein, matrix metalloproteinase-9 (MMP-9), hyaluronic acid (HA), immunoglobulin E (IgE) and cytokines (TF-alpha, IL-6 and MIP-20), lactate dehydrogenase (LDH) and GSH-S-transferase (GST).
RESULTS: The LC50 value for exposed rats was ca. 53 mg BAC in m3 air for 4 h. All the rats survived single and repeated inhalation exposure to 30 mg/m3 BAC. After single and repeated exposure, lung weight, total protein, HA and LDH activity in BALF of exposed rats were higher than in controls while CC16 levels were decreased. A significantly higher BALF concentration of IL-6 and IgE was noted in animals exposed to single and repeated doses. BALF concentrations of MMP-9, TNF-alpha, and MIP-2 in exposed rats were similar to those in control animals.
CONCLUSION: BAC may be classified to class I acute inhalation toxicity. It showed a strong inflammatory and irritant activity on the lungs after 6h inhalation and stimulated dynamic patterns of IL-6 and IgE production and protein infiltration from blood vessels to BALF. Continued exposure resulted in cellular destruction, a statistically significant increase in LDH activity and a continuous decrease in CC16 concentration in BALF.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18715840     DOI: 10.2478/v10001-008-0020-1

Source DB:  PubMed          Journal:  Int J Occup Med Environ Health        ISSN: 1232-1087            Impact factor:   1.843


  6 in total

1.  Pulmonary fibrosis in response to environmental cues and molecular targets involved in its pathogenesis.

Authors:  Toshinori Yoshida; Aya Ohnuma; Haruka Horiuchi; Takanori Harada
Journal:  J Toxicol Pathol       Date:  2011-03-31       Impact factor: 1.628

2.  Evaluation of pulmonary toxicity of benzalkonium chloride and triethylene glycol mixtures using in vitro and in vivo systems.

Authors:  Doyoung Kwon; Yeon-Mi Lim; Jung-Taek Kwon; Ilseob Shim; Eunji Kim; Doo-Hee Lee; Byung-Il Yoon; Pilje Kim; Hyun-Mi Kim
Journal:  Environ Toxicol       Date:  2019-02-20       Impact factor: 4.119

3.  Assessment of respiratory and systemic toxicity of Benzalkonium chloride following a 14-day inhalation study in rats.

Authors:  Hye-Yeon Choi; Yong-Hoon Lee; Cheol-Hong Lim; Yong-Soon Kim; In-Seop Lee; Ji-Min Jo; Ha-Young Lee; Hyo-Geun Cha; Hee Jong Woo; Dong-Seok Seo
Journal:  Part Fibre Toxicol       Date:  2020-01-28       Impact factor: 9.400

Review 4.  Quaternary ammonium compounds in hypersensitivity reactions.

Authors:  Marine Peyneau; Luc de Chaisemartin; Nicolas Gigant; Sylvie Chollet-Martin; Saadia Kerdine-Römer
Journal:  Front Toxicol       Date:  2022-09-16

5.  An aerosol formulation of R-salbutamol sulfate for pulmonary inhalation.

Authors:  Xuemei Zhang; Qing Liu; Junhua Hu; Ling Xu; Wen Tan
Journal:  Acta Pharm Sin B       Date:  2014-01-18       Impact factor: 11.413

6.  SARS-CoV-2 human disinfection chambers: a critical analysis.

Authors:  Aseni Wickramatillake; Changa Kurukularatne
Journal:  Occup Med (Lond)       Date:  2020-07-17       Impact factor: 1.611

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.